VRTX

Vertex Pharmaceuticals Incorporated NMS · VRTX

$481.80 +1.30 (+0.27%)

Neutral · -0.09σ

+ Compare Open in Sniper

Valuation

Market cap $122.3B

P/E (ttm) 28.6

Forward P/E 22.6

Beta (5y) 0.29

Shares out 253.8M

Div yield —

Profitability & returns

ROE 24.2%

Net margin 35.5%

FCF margin 22.8%

Debt / equity 0.10

Trading information

Last price $481.80

Day range $473.56 – $484.99

52-wk range $412.27 – $533.67

Avg volume 1.5M

RSI (2) 45.0

Trend zone Neutral

52-week range · today's price

$412.27$533.67

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-03

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F…